Advertisement

Return to work after surgical treatment for malignant pleural mesothelioma: report of a case

  • Masaru TakenakaEmail author
  • Yoshinobu Ichiki
  • Akihiro Taira
  • Shinji Shinohara
  • Taiji Kuwata
  • Ayako Hirai
  • Naoko Imanishi
  • Kazue Yoneda
  • Noriaki Tsubota
  • Fumihiro Tanaka
Case Report
  • 21 Downloads

Abstract

We report the case of a 56-year-old woman who underwent pleural biopsy to identify the cause of the right pleural effusion. The pathological diagnosis was epithelial malignant pleural mesothelioma. The patient worked as a junior high school teacher and strongly hoped for continuing work. Thus, we performed pleurectomy/decortication (P/D) as a curative surgery. The operative findings showed pleural thickening that in the lower lobe of the lung. Thus, peeling of the lower lobe was performed. Pleural biopsy was only performed on the upper and middle lobes. As a result, the operation was limited P/D. The pathological findings showed a small number of mesothelioma cells in the upper and middle lobes. The patient received four courses of cisplatin plus pemetrexed systemic chemotherapy after surgery. Continuous maintenance chemotherapy using pemetrexed has been performed until the time of writing. At present, she has continued her work for 6 years after the operation and has extended her retirement age without recurrence.

Keywords

Malignant pleural mesothelioma Pleurectomy/decortication Incomplete resection Maintenance chemotherapy Long-term survival 

Abbreviations

MPM

Malignant pleural mesothelioma

EPP

Extrapleural pneumonectomy

P/D

Pleurectomy/decortication

CT

Computed tomography

IASLC

International association for the study of lung cancer

Notes

Acknowledgements

We thank Dr. Atsuji Matsuyama for helpful assistance in pathological diagnosis.

Funding

None.

References

  1. 1.
    Mancuso MR, Neal JW. Novel sustemic therapy against malignant pleural mesothelioma. Transl Lung Cancer Res. 2017;6:295–314.CrossRefGoogle Scholar
  2. 2.
    Cameron RB. Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument. Ann Surg Oncol. 2007;14:1249–53.CrossRefGoogle Scholar
  3. 3.
    Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma ond radical surgery (MARS) randomized feasibility study. Lancet Oncol. 2011;12:763–72.CrossRefGoogle Scholar
  4. 4.
    Rusch VW, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7:1632–9.Google Scholar
  5. 5.
    Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135:620–6.CrossRefGoogle Scholar
  6. 6.
    Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F, Tognon MG. New perspectives on diagnosis and therapy of malignant pleural mesothelioma. Front Oncol. 2018;8:91.CrossRefGoogle Scholar
  7. 7.
    Tanaka F, Imanishi N, Takenaka M, Taira A. Non-incisional pleurectomy-decortication for malignant pleural mesothelioma. Surg Today. 2018;48:656–8.CrossRefGoogle Scholar
  8. 8.
    Takeda T, Itano H, Fukita S, Saitoh M, Takeda S. Long progeression-free survival by pemetrexed continuation maintenance thrapy following cisplatin-based chemotherapy in malignant pleural mesothelioma. Intern Med. 2014;53:2347–51.CrossRefGoogle Scholar
  9. 9.
    Jing XQ, Zhou L, Sun XD, Yu JM, Meng X. Pemetrexed maintenance therapy following bevacizumab-containing first-line chemotherapy in advanced maliganant pleural mesothelioma. Medicine. 2016;95:e3351.CrossRefGoogle Scholar
  10. 10.
    Fujimoto N, Aoe K, Kozuki T, Oze I, Kato K, Kishimoto T, et al. A phase II trial of first-line combination chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for unresectable malignant pleural mesothelioma: a study protocol. Clin Lung Cancer. 2018;19:e705-7.Google Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2019

Authors and Affiliations

  • Masaru Takenaka
    • 1
    Email author
  • Yoshinobu Ichiki
    • 1
  • Akihiro Taira
    • 1
  • Shinji Shinohara
    • 1
  • Taiji Kuwata
    • 1
  • Ayako Hirai
    • 1
  • Naoko Imanishi
    • 1
  • Kazue Yoneda
    • 1
  • Noriaki Tsubota
    • 2
  • Fumihiro Tanaka
    • 1
  1. 1.Second Department of Surgery, School of MedicineUniversity of Occupational and Environmental HealthKitakyushuJapan
  2. 2.Thoracic SurgeryKita-Harima Medical CenterOno CityJapan

Personalised recommendations